Biotech4 hours ago
New Molecular Clues Explain Aggressive Neuroblastoma and Point to Targeted Treatments
Researchers at the Institute of Biomedicine of Seville identified molecular mechanisms explaining aggressive neuroblastoma. Dysregulation of Rho GTPase signaling, especially reduced Cdc42 activity driven by ARHGAP31,...